Moderna Inc
NASDAQ: MRNA
$53.29
-$0.25 (-0.5%)
Closing Price on November 5, 2024
MRNA Articles
Markets closed down slightly on Monday and got off to a mixed opening Tuesday. Here's a look at the stocks that were winning and losing in the premarket trading session.
Published:
Tuesday's top analyst upgrades and downgrades included BioNTech, ConocoPhillips, Harley-Davidson, Livent, Luminar Technologies, Meta Platforms, Moderna, Snap, Twitter, United Airlines, US Foods,...
Published:
Wednesday's top analyst upgrades and downgrades included Confluent, DraftKings, Fastly, Halliburton, Moderna, Netflix, Southern Company, Splunk, Taiwan Semiconductor, Twilio, ViacomCBS, VMware, Xcel...
Published:
A possible end to a long-running acquisition effort weighed on tech stocks Tuesday morning.
Published:
Friday's top analyst upgrades and downgrades included Beyond Meat, Carvana, Embraer, Lennar, Moderna, Paysafe, Peloton Interactive, PulteGroup, Ventas, VICI Properties and Vroom.
Published:
Tuesday’s top analyst upgrades and downgrades included Bloomin' Brands, Boston Beer, Bumble, Goldman Sachs, Juniper Networks, Merck, Moderna, Petco Health, Southern Company, Spirit Airlines and...
Published:
The Omicron variant of the coronavirus was having its way with global equity markets on Tuesday.
Published:
Despite Friday's sharp drop in equity prices, there were a couple of winners. Premarket trading indicated a higher open, with crude oil up well over 5%.
Published:
Tuesday's top analyst upgrades and downgrades included Airbnb, Canopy Growth, Continental Resources, DraftKings, Fisker, Moderna, Owens Corning, SunPower and Wayfair.
Published:
Here's a preview of three companies scheduled to report quarterly earnings before markets open Thursday.
Published:
Friday's top analyst upgrades and downgrades included Boeing, Cinemark, Freeport McMoRan, Intel, Moderna, Nvidia, Southwest Airlines, Urban Outfitters and Zoom Video.
Published:
Friday afternoon's analyst upgrades and downgrades included Chubb, Domino’s, Lam Research, Moderna, Riot Blockchain and more.
Published:
Vaccine maker Moderna has announced it is working on a new vaccine, and another COVID-19 treatment is getting hammered.
Published:
Here's a look at how August's most-discussed stocks on WallStreetBets performed in the month. Sometimes, talk is not cheap.
Published:
Friday’s top analyst upgrades and downgrades included BP, Cloudflare, Expedia, FireEye, Marathon Oil, Moderna, Pinduoduo, Vertex Pharmaceuticals and ViacomCBS.
Published: